Search

Health Ranger: How I beat type-2 diabetes using food, nutrition and exercise, avoiding a lifetime of insulin and toxic pharma drugs

HEALTH RANGER: HOW I BEAT TYPE-2 DIABETES USING FOOD, NUTRITION AND EXERCISE, AVOIDING A LIFETIME OF INSULIN AND TOXIC PHARMA DRUGS

Two decades ago, I was on the path to a lifetime of type-2 diabetes. Living on processed foods and lacking exercise, I suffered from...

Proteus Digital Health CEO talks about significance of FDA's digital pill approval

PROTEUS DIGITAL HEALTH CEO TALKS ABOUT SIGNIFICANCE OF FDA'S DIGITAL PILL APPROVAL

The FDA's approval of Abilify Mycite, which is expected to come to market early next year marks a milestone for mental health patients...

 
 
 
Propeller, Express Scripts Partner to Monitor Asthma, COPD Patients

PROPELLER, EXPRESS SCRIPTS PARTNER TO MONITOR ASTHMA, COPD PATIENTS

Propeller Health, a startup developing Internet-connected inhalers and complementary software to help people with respiratory disease...

At Seattle Children's, Another Piece of Ambitious CAR-T Plan in Place

AT SEATTLE CHILDREN'S, ANOTHER PIECE OF AMBITIOUS CAR-T PLAN IN PLACE

The researchers and doctors at Seattle Children's are embarking upon a complicated quest, involving multiple clinical studies of cutting-edge...

 
 
 
 
 
 
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases

X4 PHARMA PULLS IN $27M FOR IMMUNE DRUG IN CANCER, RARE DISEASES

The immune system can't fight disease if its cells don't reach their targets. In some cancers and rare immune deficiency disorders,...

FDA gives greenlight to first digital ingestion tracking system

FDA GIVES GREENLIGHT TO FIRST DIGITAL INGESTION TRACKING SYSTEM

Abilify MyCite, developed in collaboration between Proteus Digital Health and Otsuka Pharmaceutical, has an ingestible sensor embedded...

 
 
 

SAWAI PHARMA UNLOADS 20% STAKE IN ITS U.S. SUBSIDIARY FOR $211M

The transaction is expected to close by the end of March 2018.

 
 
 
We are witnessing a perfect example of how pharma's hogs are going to get slaughtered

WE ARE WITNESSING A PERFECT EXAMPLE OF HOW PHARMA'S HOGS ARE GOING TO GET SLAUGHTERED

At a luncheon Thursday, Mallinckrodt Pharma executives said at least one big payer has started putting restrictions on its $36,000-a-dose...

Election 2017: Maine votes to expand Medicaid and Ohio rejects drug price reduction

ELECTION 2017: MAINE VOTES TO EXPAND MEDICAID AND OHIO REJECTS DRUG PRICE REDUCTION

The results in Maine could energize similar efforts in other states. Similar ballot initiatives are being undertaken in Idaho, Kansas...

 
 
 
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOS & More

BIOTECH ROUNDUP: OPIOID NEWS, ASH PREVIEW, BOSTON BIO IPOS & MORE

The rising death toll from opioids has prompted policymakers to try various ways to take on the problem. President Trump's opioid commission...

 
 
 

DAIICHI SANKYO POSTS RARE CANCER DATA FROM SUSPENDED ENLIVEN TEST

A year ago, we reported that Japanese pharma Daiichi Sankyo and partner Plexxikon had suspended a trial of its rare cancer candidate...

 
 
 
Is the $75K voice-activated tech contest run by HITLAB and Novo Nordisk transparent enough?

IS THE $75K VOICE-ACTIVATED TECH CONTEST RUN BY HITLAB AND NOVO NORDISK TRANSPARENT ENOUGH?

We probe the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes contest after a complaint that the process for finalist...

Gene editing remains early-stage, but Big Pharma has taken notice

GENE EDITING REMAINS EARLY-STAGE, BUT BIG PHARMA HAS TAKEN NOTICE

Gene editing offers near-limitless medical potential. The challenge is putting it into medical practice. So how is gene editing progressing,...

 
 
 

FOSUN PHARMA TO BUY FRANCE'S TRIDEM FOR $73M

Fosun Pharma said it would buy Tridem Pharma S.A.S. for $73M, in a move to expand its market share in Europe and Africa.

Why diversifying the sciences requires an industry-wide approach

WHY DIVERSIFYING THE SCIENCES REQUIRES AN INDUSTRY-WIDE APPROACH

I have seen how difficult it is for even very skilled, very qualified women to get placed on a board, and it has renewed my commitment...